Skip to main content
logo
Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China flag China · Delayed Price · Currency is CNY
89.69
+1.69 (1.92%)
Mar 24, 2026, 10:15 AM CST

SHA:688578 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
39,60046,86826,95518,7478,85613,590
Market Cap Growth
12.99%73.87%43.78%111.69%-34.83%6.04%
Enterprise Value
36,32543,59323,92716,4946,91611,015
Last Close Price
88.00104.1559.4540.8419.2929.61
PE Ratio
18.1421.4918.8529.1067.85743.66
Forward PE
17.2321.6217.6428.7074.26109.82
PS Ratio
7.669.067.589.2911.2025.64
PB Ratio
6.097.215.104.712.784.57
P/TBV Ratio
6.277.425.174.792.844.68
P/FCF Ratio
--20.8030.90--
P/OCF Ratio
--17.2127.7996.65463.96
EV/Sales Ratio
7.028.436.738.178.7420.78
EV/EBITDA Ratio
13.9416.7315.8328.18117.62-
EV/EBIT Ratio
14.1416.9716.2230.08179.00-
EV/FCF Ratio
--18.4727.18--
Debt / Equity Ratio
0.000.00000.000.00
Debt / EBITDA Ratio
0.000.000.000.000.03-
Debt / FCF Ratio
--0.000.00--
Net Debt / Equity Ratio
-0.50-0.50-0.69-0.63-0.64-0.76
Net Debt / EBITDA Ratio
-1.26-1.26-2.40-4.29-34.6140.26
Net Debt / FCF Ratio
---2.80-4.1438.9913.84
Asset Turnover
--0.690.520.240.17
Inventory Turnover
--3.622.321.781.90
Quick Ratio
--6.737.188.6214.59
Current Ratio
--6.967.468.9815.21
Return on Equity (ROE)
37.03%37.03%30.86%17.97%4.24%0.63%
Return on Assets (ROA)
--17.91%8.77%0.73%-1.43%
Return on Invested Capital (ROIC)
68.68%90.72%83.25%41.02%4.13%-13.81%
Return on Capital Employed (ROCE)
--27.70%13.80%1.20%-2.30%
Earnings Yield
5.51%4.65%5.30%3.44%1.47%0.13%
FCF Yield
--4.81%3.24%-0.59%-1.20%
Dividend Yield
0.89%-1.09%0.98%--
Payout Ratio
--20.46%---
Buyback Yield / Dilution
-0.03%-0.03%0.18%-0.09%1.49%-23.59%
Total Shareholder Return
0.86%-0.03%1.28%0.89%1.49%-23.59%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.